Filter
1864
Text search:
drug
trial
Featured
Recommendations
178
New Publications
320
Language
Document type
No document type
1057
Guidelines
315
Studies & Reports
313
Manuals
80
Strategic & Response Plan
30
Fact sheets
30
Training Material
17
Situation Updates
9
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
95
Global
72
South Africa
55
Western and Central Europe
40
Kenya
29
Africa
29
Uganda
27
Ethiopia
25
Russia
23
Tanzania
22
Eastern Europe
22
Nigeria
21
Zambia
21
Liberia
20
Ukraine
19
Sierra Leone
17
Zimbabwe
17
Latin America and the Carribbean
17
Ghana
15
Nepal
15
Malawi
15
Philippines
14
Bangladesh
13
Rwanda
12
Brazil
12
Myanmar / Burma
11
Colombia
9
South–East Asia Region
9
South Sudan
8
Cambodia
8
Mozambique
8
Namibia
8
East and Southern Africa
8
Asia
8
Germany
7
Indonesia
7
Lesotho
7
West and Central Africa
7
Congo, Democratic Republic of
6
USA
6
Thailand
6
Middle East and North Africa
5
Tajikistan
5
Guinea
4
Argentina
4
Eswatini/ Swaziland
4
Vietnam
4
Senegal
3
Cameroon
3
Syria
3
Sudan
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Georgia
3
Burkina Faso
2
Guinea-Bissau
2
Haiti
2
China
2
North Macedonia
2
Hungary
2
Botswana
2
Bolivia
2
Mexico
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Kyrgyzstan
2
Jamaica
2
Spain
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Pakistan
1
Jordan
1
Lebanon
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Ecuador
1
Bhutan
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Iran
1
Kazakhstan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
463
Clinical Guidelines
248
Public Health
92
Women & Child Health
81
Key Resources
26
Pharmacy & Technologies
18
Capacity Building
11
Toolboxes
HIV
285
Mental Health
273
TB
221
COVID-19
127
NTDs
119
NCDs
62
Ebola & Marburg
44
AMR
42
Pharmacy
40
Malaria
39
Caregiver
21
Disability
18
Refugee
18
Planetary Health
15
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
9
Cholera
6
Polio
6
2.0 Rapid Response
6
Conflict
5
Natural Hazards
4
Zika
4
Specific Hazards
3
Social Ethics
3
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d
...
A new frontier for integrated care.
Until now, most efforts to promote integrated care have focused on bridging the gaps between health and social care or between primary and secondary care. But the NHS five year forward view has highlighted a third dimension – bringing together physical and ment
...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i
...
Overwhelming evidence shows that a range of health concerns—mental illness, substance dependence, HIV/AIDS, and noncommunicable diseases—affect prisoners disproportionately. But, while incarceration poses risks to health—including inadequate nutrition and exposure to violence—prisons also pr
...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e
...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Expanded IMPACT Program in Zimbabwe
Lea Toto and APHIAplus Nuru ya Bonde programs in Kenya Yekokeb Berhan Program for Highly Vulnerable Children in Ethiopia
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de
...
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i
...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida
...
Asylum and Migration Working Paper 1
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
UNAIDS 2016 / Meeting Report
DHS Working Papers No. 85
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me
...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m
...
